\-\ Texto\\:\\ \ \(0\)\
\-\ temp\\ 100\\.8\\,\\ bp\\ 140\\/88\\,\\ hr\\ 70\\,\\ rr\\ 17\\.\\ \\ remainder\\ of\\ physical\\ exam\\ and\\ labs\\ were\\ unavailable\\.\ \(0\)\
\-\ the\\ prognosis\\ for\\ this\\ patient\\ is\\ poor\\.\\ \\ possible\\ therapies\\ are\\ palliative\\ chemotherapy\\ and\\ palliative\\ radiotherapy\\.\\ \\ the\\ pt\\ was\\ taken\\ to\\ the\\ special\\ procedures\\ lab\\ the\\ day\\ the\\ chest\\ film\\ was\\ read\\ by\\ a\\ radiologist\\ and\\ the\\ portion\\ of\\ the\\ catheter\\ was\\ removed\\ through\\ an\\ intravascular\\ approach\\.\ \(0\)\
\-\ study\\ from\\ december\\ demonstrates\\ increase\\ in\\ size\\ and\\ quantity\\ of\\ masses\\ over\\ all\\ lung\\ fields\\ as\\ compared\\ to\\ previous\\ study\\ of\\ august\\ in\\ the\\ same\\ year\\.\\ \\ largest\\ mass\\,\\ measuring\\ 3cm\\,\\ is\\ located\\ peripherally\\ in\\ the\\ left\\ lung\\ field\\.\\ \\ there\\ is\\ prominent\\ lymphadenopathy\\ in\\ both\\ hila\\.\\ \\ a\\ 9\\.5\\ cm\\ length\\ of\\ catheter\\ is\\ present\\ in\\ the\\ left\\ pulmonary\\ artery\\ and\\ extends\\ into\\ the\\ inferior\\ branch\\.\ \(0\)\
\-\ stage\\ iv\\ melanoma\ \(0\)\
\-\ migration\\ of\\ broken\\ catheter\ \(0\)\
\-\ mass\\ lesion\\:\ \(1\)\
\-\ granulomatous\\ disease\ \(29\)\
\-\ inflammation\ \(200\)\
\-\ benign\\ neoplasm\ \(14\)\
\-\ malignant\\ primary\ \(1\)\
\-\ metastatic\\ disease\ \(243\)\
\-\ congenital\\ abnormality\ \(6\)\
\-\ 52\\ y\\/o\\ woman\\ with\\ hx\\ of\\ resected\\ skin\\ lesion\\.\\ \\ had\\ latest\\ pa\\ and\\ lateral\\ done\\ as\\ part\\ of\\ a\\ fever\\ work\\ up\\,\\ with\\ prior\\ study\\ in\\ august\\ 2004\\ and\\ ct\\ in\\ november\\ 2004\\.\\ \\ past\\ surgical\\ history\\ consists\\ of\\ placement\\ of\\ a\\ port\\-a\\-cath\\.\ \(0\)\
\-\ complication\\ rates\\.\\ \\ next\\ to\\ skin\\,\\ subcutaneous\\ tissue\\,\\ and\\ lymph\\ nodes\\,\\ the\\ lungs\\ are\\ the\\ most\\ common\\ sites\\ of\\ melanoma\\ to\\ metastasize\\.\\ \\ this\\ is\\ thought\\ to\\ be\\ due\\ to\\ the\\ capillary\\ beds\\ in\\ the\\ lung\\ parenchyma\\.\\ \\ once\\ there\\ is\\ metastasis\\ to\\ the\\ lungs\\ or\\ other\\ distant\\ sites\\,\\ the\\ disease\\ is\\ stage\\ iv\\ and\\ has\\ a\\ 5\\-year\\ survival\\ of\\ 8\\-10\\%\\.\\ \\ placement\\ of\\ indwelling\\ catheters\\ is\\ not\\ without\\ complications\\.\\ \\ at\\ the\\ time\\ of\\ insertion\\ pneumothorax\\ is\\ a\\ known\\ complication\\.\\ \\ once\\ in\\ place\\ complications\\ include\\ infection\\,\\ thrombosis\\ with\\ possible\\ svc\\ syndrome\\,\\ erosion\\ of\\ svc\\,\\ pe\\ and\\ breakage\\ with\\ migration\\ as\\ in\\ this\\ case\\.\\ \\ migration\\ of\\ the\\ catheter\\ has\\ its\\ own\\ complications\\ to\\ include\\ pulmonary\\ infarctions\\,\\ pe\\,\\ perforation\\ and\\ arrhythmias\\.\ \(0\)\
\-\ up\\ to\\ date\\ \\â\\€\\“\\ imagining\\ studies\\ in\\ melanoma\ \(0\)\
\-\ harrison\\â\\€\\™s\\ principals\\ of\\ internal\\ medicine\\ 15th\\ ed\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ catheter\\:\\ 0\\.046134699130945665\ \(0\)\
\-\ migration\\:\\ 0\\.042592570013535974\ \(0\)\
\-\ melanoma\\:\\ 0\\.03675144208746901\ \(0\)\
\-\ svc\\:\\ 0\\.0308051343471421\ \(0\)\
\-\ august\\:\\ 0\\.029551518890320698\ \(0\)\
\-\ palliative\\:\\ 0\\.02923932871529367\ \(0\)\
\-\ complications\\:\\ 0\\.028535164002910594\ \(0\)\
\-\ sites\\:\\ 0\\.02616087270003835\ \(0\)\
\-\ 140\\/88\\:\\ 0\\.024762692202153085\ \(0\)\
\-\ beds\\:\\ 0\\.024762692202153085\ \(0\)\
\-\ breakage\\:\\ 0\\.024762692202153085\ \(0\)\
\-\ principals\\:\\ 0\\.024762692202153085\ \(0\)\
\-\ once\\:\\ 0\\.024566669480203265\ \(0\)\
\-\ study\\:\\ 0\\.023693522670168193\ \(0\)\
\-\ complication\\:\\ 0\\.023542391071248465\ \(0\)\
\-\ 100\\.8\\:\\ 0\\.022815649560130765\ \(0\)\
\-\ imagining\\:\\ 0\\.022815649560130765\ \(0\)\
\-\ 15th\\:\\ 0\\.022815649560130765\ \(0\)\
\-\ pe\\:\\ 0\\.021566206076100693\ \(0\)\
\-\ quantity\\:\\ 0\\.020868606918108448\ \(0\)\
\-\ latest\\:\\ 0\\.020868606918108448\ \(0\)\
\-\ lung\\:\\ 0\\.020858082473922016\ \(0\)\
\-\ stage\\:\\ 0\\.020477721510833408\ \(0\)\
\-\ port\\-a\\-cath\\:\\ 0\\.020241799189697745\ \(0\)\
\-\ harrison\\:\\ 0\\.020241799189697745\ \(0\)\
\-\ infarctions\\:\\ 0\\.019729659985220346\ \(0\)\
\-\ placement\\:\\ 0\\.01948545445645522\ \(0\)\
\-\ 8\\-10\\:\\ 0\\.018921564276086128\ \(0\)\
\-\ indwelling\\:\\ 0\\.018921564276086128\ \(0\)\
\-\ arrhythmias\\:\\ 0\\.018921564276086128\ \(0\)\
\-\ skin\\:\\ 0\\.01843892660246617\ \(0\)\
\-\ 9\\.5\\:\\ 0\\.018294756547675428\ \(0\)\
\-\ lungs\\:\\ 0\\.018178587629102672\ \(0\)\
\-\ hila\\:\\ 0\\.018027031323505974\ \(0\)\
\-\ 2004\\.\\:\\ 0\\.01755777827669933\ \(0\)\
\-\ 5\\-year\\:\\ 0\\.01755777827669933\ \(0\)\
\-\ iv\\:\\ 0\\.017519241221691538\ \(0\)\
\-\ 17\\.\\:\\ 0\\.017155809614787326\ \(0\)\
\-\ broken\\:\\ 0\\.017155809614787326\ \(0\)\
\-\ november\\:\\ 0\\.01697452163406381\ \(0\)\
\-\ metastasize\\:\\ 0\\.01697452163406381\ \(0\)\
\-\ catheters\\:\\ 0\\.01697452163406381\ \(0\)\
\-\ december\\:\\ 0\\.016804227752556973\ \(0\)\
\-\ intravascular\\:\\ 0\\.016210662882705267\ \(0\)\
\-\ possible\\:\\ 0\\.01616843943193299\ \(0\)\
\-\ therapies\\:\\ 0\\.016079988681483658\ \(0\)\
\-\ special\\:\\ 0\\.01561073563467701\ \(0\)\
\-\ 3cm\\:\\ 0\\.01561073563467701\ \(0\)\
\-\ read\\:\\ 0\\.015504723477421822\ \(0\)\
\-\ own\\:\\ 0\\.01540256717357105\ \(0\)\
\-\ unavailable\\:\\ 0\\.015027478992041493\ \(0\)\
\-\ radiotherapy\\:\\ 0\\.014619664357646835\ \(0\)\
\-\ peripherally\\:\\ 0\\.014331309992309523\ \(0\)\
\-\ is\\:\\ 0\\.014215216307479019\ \(0\)\
\-\ capillary\\:\\ 0\\.014132946039461339\ \(0\)\
\-\ pulmonary\\:\\ 0\\.014025563540562154\ \(0\)\
\-\ distant\\:\\ 0\\.014008081537857873\ \(0\)\
\-\ rates\\:\\ 0\\.013947670849034944\ \(0\)\
\-\ radiologist\\:\\ 0\\.01377386353522009\ \(0\)\
\-\ largest\\:\\ 0\\.013610186827006676\ \(0\)\
\-\ include\\:\\ 0\\.013467154427136441\ \(0\)\
\-\ temp\\:\\ 0\\.013308935337249377\ \(0\)\
\-\ consists\\:\\ 0\\.013169618086857883\ \(0\)\
\-\ fields\\:\\ 0\\.013080436350019174\ \(0\)\
\-\ in\\:\\ 0\\.01302070093130001\ \(0\)\
\-\ procedures\\:\\ 0\\.012993999106573235\ \(0\)\
\-\ branch\\:\\ 0\\.012993999106573235\ \(0\)\
\-\ insertion\\:\\ 0\\.012993999106573235\ \(0\)\
\-\ 2004\\:\\ 0\\.012910142468512334\ \(0\)\
\-\ up\\:\\ 0\\.012909253657607997\ \(0\)\
\-\ survival\\:\\ 0\\.012869134604969771\ \(0\)\
\-\ 52\\:\\ 0\\.012788872322823547\ \(0\)\
\-\ approach\\:\\ 0\\.012597710909213952\ \(0\)\
\-\ subcutaneous\\:\\ 0\\.012488962279492912\ \(0\)\
\-\ perforation\\:\\ 0\\.01235021858474691\ \(0\)\
\-\ field\\:\\ 0\\.012316577598660628\ \(0\)\
\-\ rr\\:\\ 0\\.012250480695823006\ \(0\)\
\-\ next\\:\\ 0\\.01218590339743902\ \(0\)\
\-\ erosion\\:\\ 0\\.012122777397854587\ \(0\)\
\-\ date\\:\\ 0\\.012061038895835555\ \(0\)\
\-\ length\\:\\ 0\\.012030671153969781\ \(0\)\
\-\ hx\\:\\ 0\\.011883570071055971\ \(0\)\
\-\ resected\\:\\ 0\\.011883570071055971\ \(0\)\
\-\ disease\\:\\ 0\\.011770260178784023\ \(0\)\
\-\ lab\\:\\ 0\\.011743790549822646\ \(0\)\
\-\ hr\\:\\ 0\\.01168976987024993\ \(0\)\
\-\ place\\:\\ 0\\.011663144184984358\ \(0\)\
\-\ part\\:\\ 0\\.011636768509844358\ \(0\)\
\-\ granulomatous\\:\\ 0\\.011584748712745379\ \(0\)\
\-\ 70\\:\\ 0\\.011533674782736416\ \(0\)\
\-\ \\,\\:\\ 0\\.011406322985278963\ \(0\)\
\-\ prognosis\\:\\ 0\\.011385799126878489\ \(0\)\
\-\ medicine\\:\\ 0\\.011385799126878489\ \(0\)\
\-\ remainder\\:\\ 0\\.011314681688720372\ \(0\)\
\-\ pneumothorax\\:\\ 0\\.011268251065261914\ \(0\)\
\-\ work\\:\\ 0\\.011245320417399101\ \(0\)\
\-\ thought\\:\\ 0\\.011046956464550919\ \(0\)\
\-\ as\\:\\ 0\\.010892507072141526\ \(0\)\
\-\ nodes\\:\\ 0\\.010841829680801229\ \(0\)\
\-\ removed\\:\\ 0\\.01082211739805222\ \(0\)\
\-\ poor\\:\\ 0\\.01080254248424297\ \(0\)\
\-\ \\â\\€\\“\\:\\ 0\\.01080254248424297\ \(0\)\
\-\ to\\:\\ 0\\.010796665662884484\ \(0\)\
\-\ bp\\:\\ 0\\.010420148736140217\ \(0\)\
\-\ extends\\:\\ 0\\.010403175942724593\ \(0\)\
\-\ thrombosis\\:\\ 0\\.010303438053800688\ \(0\)\
\-\ parenchyma\\:\\ 0\\.010222945762338958\ \(0\)\
\-\ lymphadenopathy\\:\\ 0\\.0102071204316697\ \(0\)\
\-\ inflammation\\:\\ 0\\.0102071204316697\ \(0\)\
\-\ compared\\:\\ 0\\.010160172451406383\ \(0\)\
\-\ ed\\:\\ 0\\.010144695890139614\ \(0\)\
\-\ increase\\:\\ 0\\.010068566873909864\ \(0\)\
\-\ pa\\:\\ 0\\.010038683732884426\ \(0\)\
\-\ taken\\:\\ 0\\.010009115157078282\ \(0\)\
\-\ done\\:\\ 0\\.00995089568933357\ \(0\)\
\-\ same\\:\\ 0\\.009893858424837096\ \(0\)\
\-\ located\\:\\ 0\\.009879778251175454\ \(0\)\
\-\ prominent\\:\\ 0\\.009851827883610375\ \(0\)\
\-\ lesion\\:\\ 0\\.00977840014606997\ \(0\)\
\-\ lymph\\:\\ 0\\.009689725867822041\ \(0\)\
\-\ measuring\\:\\ 0\\.009599313827103217\ \(0\)\
\-\ previous\\:\\ 0\\.009321208423239595\ \(0\)\
\-\ film\\:\\ 0\\.009219463301233084\ \(0\)\
\-\ its\\:\\ 0\\.00905767259397652\ \(0\)\
\-\ has\\:\\ 0\\.00901516837356336\ \(0\)\
\-\ metastasis\\:\\ 0\\.008985245298595299\ \(0\)\
\-\ studies\\:\\ 0\\.008964890218480785\ \(0\)\
\-\ pt\\:\\ 0\\.008924617288294249\ \(0\)\
\-\ abnormality\\:\\ 0\\.008855499842220652\ \(0\)\
\-\ congenital\\:\\ 0\\.008778536431579881\ \(0\)\
\-\ portion\\:\\ 0\\.008694400694828894\ \(0\)\
\-\ malignant\\:\\ 0\\.008676041225784553\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.008603780295339508\ \(0\)\
\-\ labs\\:\\ 0\\.008348241592514433\ \(0\)\
\-\ was\\:\\ 0\\.008328181366969271\ \(0\)\
\-\ benign\\:\\ 0\\.00828384934559888\ \(0\)\
\-\ neoplasm\\:\\ 0\\.008174597123348112\ \(0\)\
\-\ inferior\\:\\ 0\\.008144147082469277\ \(0\)\
\-\ fever\\:\\ 0\\.008121524231887545\ \(0\)\
\-\ masses\\:\\ 0\\.008114023589876649\ \(0\)\
\-\ this\\:\\ 0\\.008099470898714604\ \(0\)\
\-\ size\\:\\ 0\\.008047404133086437\ \(0\)\
\-\ internal\\:\\ 0\\.008047404133086437\ \(0\)\
\-\ past\\:\\ 0\\.0076269648088382975\ \(0\)\
\-\ day\\:\\ 0\\.007620673677957667\ \(0\)\
\-\ known\\:\\ 0\\.007595649113662415\ \(0\)\
\-\ the\\:\\ 0\\.007378473060024972\ \(0\)\
\-\ \\â\\€\\™\\:\\ 0\\.0071742324147344265\ \(0\)\
\-\ artery\\:\\ 0\\.007147556157607301\ \(0\)\
\-\ there\\:\\ 0\\.007144469418342633\ \(0\)\
\-\ primary\\:\\ 0\\.007110629951954203\ \(0\)\
\-\ infection\\:\\ 0\\.0069775746462719295\ \(0\)\
\-\ s\\:\\ 0\\.006884178840209514\ \(0\)\
\-\ syndrome\\:\\ 0\\.00686490611442315\ \(0\)\
\-\ through\\:\\ 0\\.006817294995564238\ \(0\)\
\-\ all\\:\\ 0\\.006789110925368794\ \(0\)\
\-\ time\\:\\ 0\\.006779778728200316\ \(0\)\
\-\ a\\:\\ 0\\.006684266322785414\ \(0\)\
\-\ mass\\:\\ 0\\.0066767472300424974\ \(0\)\
\-\ y\\/o\\:\\ 0\\.006647834353425957\ \(0\)\
\-\ are\\:\\ 0\\.006544235238930347\ \(0\)\
\-\ cm\\:\\ 0\\.006438078982631983\ \(0\)\
\-\ due\\:\\ 0\\.00640527290155292\ \(0\)\
\-\ common\\:\\ 0\\.006281649471787632\ \(0\)\
\-\ prior\\:\\ 0\\.006163238124163942\ \(0\)\
\-\ both\\:\\ 0\\.006129775254736296\ \(0\)\
\-\ over\\:\\ 0\\.006111355590280794\ \(0\)\
\-\ metastatic\\:\\ 0\\.006042442144989018\ \(0\)\
\-\ physical\\:\\ 0\\.005889059746014714\ \(0\)\
\-\ chest\\:\\ 0\\.005743620786678423\ \(0\)\
\-\ into\\:\\ 0\\.0057115909212351315\ \(0\)\
\-\ tissue\\:\\ 0\\.005689385360821892\ \(0\)\
\-\ without\\:\\ 0\\.0056517223774105625\ \(0\)\
\-\ \\%\\:\\ 0\\.0055992163858033924\ \(0\)\
\-\ of\\:\\ 0\\.0055633837459713575\ \(0\)\
\-\ and\\:\\ 0\\.0055620760198157385\ \(0\)\
\-\ woman\\:\\ 0\\.005544671200811534\ \(0\)\
\-\ most\\:\\ 0\\.005541671746427179\ \(0\)\
\-\ other\\:\\ 0\\.005532692552534968\ \(0\)\
\-\ were\\:\\ 0\\.005450242518791913\ \(0\)\
\-\ present\\:\\ 0\\.005421372904302474\ \(0\)\
\-\ left\\:\\ 0\\.0053713779172635655\ \(0\)\
\-\ exam\\:\\ 0\\.005273129044802073\ \(0\)\
\-\ case\\:\\ 0\\.005251416946256378\ \(0\)\
\-\ demonstrates\\:\\ 0\\.005243317982171871\ \(0\)\
\-\ lateral\\:\\ 0\\.0051872697910801974\ \(0\)\
\-\ had\\:\\ 0\\.00517935342483345\ \(0\)\
\-\ surgical\\:\\ 0\\.0050455667703692515\ \(0\)\
\-\ by\\:\\ 0\\.0039968283799013335\ \(0\)\
\-\ be\\:\\ 0\\.0037015638296177783\ \(0\)\
\-\ from\\:\\ 0\\.003557403688635428\ \(0\)\
\-\ not\\:\\ 0\\.0034685917745559984\ \(0\)\
\-\ ct\\:\\ 0\\.0033575945320001204\ \(0\)\
\-\ an\\:\\ 0\\.0033192833266424996\ \(0\)\
\-\ history\\:\\ 0\\.003315209375581695\ \(0\)\
\-\ at\\:\\ 0\\.003252143687729306\ \(0\)\
\-\ \\:\\:\\ 0\\.0031749292584007443\ \(0\)\
\-\ or\\:\\ 0\\.0028132661487744594\ \(0\)\
\-\ year\\:\\ 0\\.0026856889586317828\ \(0\)\
\-\ patient\\:\\ 0\\.0024061571093156966\ \(0\)\
\-\ for\\:\\ 0\\.0020480565973109975\ \(0\)\
\-\ \\.\\:\\ 0\\.001894638162498818\ \(0\)\
\-\ with\\:\\ 0\\.0013146536639313453\ \(0\)\
